ArticleBMC cancer2014

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.

Robert J Canter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.